Skip to main content

Table 1 The precision and accuracy of LTG, MHD, and OXC in human blood plasma (mean ± standard deviation)

From: Development and validation of an improved HPLC-UV method for simultaneous determination of lamotrigine and oxcarbazepine and its active metabolite 10,11-dihydro-10-hydroxycarbazepine in human blood plasma and comparison with an UHPLC-MS/MS method

Measurement

Drug

Analyte concentration (mg/L)

Measured concentration (mg/L)

Bias (%)

Coefficient variation (%)

Intra-day, n = 5

LTG

96

100.015 ± 8.078

4.18

8.08

48

46.138 ± 2.457

− 3.88

5.32

24

22.082 ± 0.789

− 7.99

3.57

6

5.703 ± 0.427

− 4.95

7.49

2.4

2.308 ± 0.08

− 3.84

3.45

MHD

96

98.85 ± 7.1

2.97

7.18

48

46.773 ± 2.372

− 2.56

5.07

24

22.536 ± 0.788

− 6.10

3.49

6

5.89 ± 0.425

− 1.83

7.22

2.4

2.188 ± 0.102

− 8.84

4.67

OXC

96

99.414 ± 7.201

3.56

7.24

48

47.06 ± 2.307

− 1.96

4.90

24

22.729 ± 0.794

− 5.30

3.49

6

5.953 ± 0.379

− 0.78

6.37

2.4

2.345 ± 0.183

− 2.30

7.79

Inter-day, n = 60

LTG

96

98.769 ± 2.952

2.88

2.99

48

46.561 ± 1.076

− 3.00

2.31

24

23.337 ± 0.491

− 2.76

2.10

6

5.878 ± 0.091

− 2.03

1.55

2.4

2.337 ± 0.084

− 2.63

3.58

MHD

96

96.934 ± 2.884

0.97

2.97

48

46.565 ± 1.416

− 2.99

3.04

24

23.468 ± 0.475

− 2.22

2.03

6

6.053 ± 0.128

0.89

2.12

2.4

2.335 ± 0.117

− 2.69

5.01

OXC

96

98.103 ± 2.908

2.19

2.96

48

46.931 ± 1.074

− 2.23

2.29

24

23.912 ± 0.473

− 0.37

1.98

6

6.114 ± 0.204

1.89

3.34

2.4

2.336 ± 0.066

− 2.68

2.83

  1. Abbreviations: LTG lamotrigine, MHD 10,11-dihydro-10-hydroxycarbazepine, OXC oxcarbazepine